CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹14,147 Cr | ₹11,772 Cr | ₹9,798 Cr | ₹8,590 Cr | ₹7,311 Cr |
What is the latest Net Current Assets ratio of CIPLA ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹14,147 Cr |
Mar2023 | ₹11,772 Cr |
Mar2022 | ₹9,798 Cr |
Mar2021 | ₹8,590 Cr |
Mar2020 | ₹7,311 Cr |
How is Net Current Assets of CIPLA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹14,147 Cr | 20.17 | |
Mar2023 | ₹11,772 Cr | 20.15 | |
Mar2022 | ₹9,798 Cr | 14.06 | |
Mar2021 | ₹8,590 Cr | 17.50 | |
Mar2020 | ₹7,311 Cr | - |
Compare Net Current Assets of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹117,832.9 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,787.0 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
MANKIND PHARMA | ₹98,888.9 Cr | -4.4% | -7.8% | 13.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 0.1% |
1.2% |
3.3% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses